|
ABHD15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.79939999997736E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.2721999999995E-05 |
| Normal-vs-Stage2 |
7.312600E-01 |
| Normal-vs-Stage3 |
6.64540000028246E-07 |
| Normal-vs-Stage4 |
1.91938999999364E-05 |
| Stage1-vs-Stage2 |
6.378200E-02 |
| Stage1-vs-Stage3 |
1.320020E-01 |
| Stage1-vs-Stage4 |
2.295400E-01 |
| Stage2-vs-Stage3 |
1.276250E-02 |
| Stage2-vs-Stage4 |
1.409500E-02 |
| Stage3-vs-Stage4 |
8.741200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73913000000026E-05 |
| Normal-vs-AfricanAmerican |
5.54360000000198E-05 |
| Normal-vs-Asian |
9.771800E-04 |
| Caucasian-vs-AfricanAmerican |
2.462200E-01 |
| Caucasian-vs-Asian |
8.270800E-01 |
| AfricanAmerican-vs-Asian |
3.295400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.863500E-03 |
| Normal-vs-Female |
1.94480000004216E-06 |
| Male-vs-Female |
3.263600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.743380E-03 |
| Normal-vs-Age(41-60Yrs) |
2.21539999999409E-05 |
| Normal-vs-Age(61-80Yrs) |
8.32410000000117E-05 |
| Normal-vs-Age(81-100Yrs) |
1.542140E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.699800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.316200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.964000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.956400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.652000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.391400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.777500E-02 |
| Classical-VS-Follicular |
6.769800E-01 |
| Classical-VS-Other |
5.432000E-01 |
| Classical-VS-Normal |
9.84459999999743E-05 |
| Tall-VS-Follicular |
1.667650E-02 |
| Tall-VS-Other |
2.868000E-01 |
| Tall-VS-Normal |
7.57509999949058E-07 |
| Follicular-VS-Other |
5.945600E-01 |
| Follicular-VS-Normal |
1.134390E-02 |
| Other-VS-Normal |
9.837600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.802200E-04 |
| Normal-vs-N1 |
3.61159999684446E-08 |
| N0-vs-N1 |
3.276000E-03 |
|
|
